Zhou J - Search Results

1

All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide.

Ran D, Zhou J, Chai Z, Li J, Xie C, Mao J, Lu L, Zhang Y, Wu S, Zhan C, Lu W. Ran D, et al. Among authors: zhou j. Theranostics. 2020 Mar 4;10(9):4073-4087. doi: 10.7150/thno.41382. eCollection 2020. Theranostics. 2020. PMID: 32226540 Free PMC article.

2

d-Retroenantiomer of Quorum-Sensing Peptide-Modified Polymeric Micelles for Brain Tumor-Targeted Drug Delivery.

Ran D, Mao J, Zhan C, Xie C, Ruan H, Ying M, Zhou J, Lu WL, Lu W. Ran D, et al. Among authors: zhou j. ACS Appl Mater Interfaces. 2017 Aug 9;9(31):25672-25682. doi: 10.1021/acsami.7b03518. Epub 2017 Jul 31. ACS Appl Mater Interfaces. 2017. PMID: 28548480

3

Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma.

Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X, Xie C, Jiang K, Li J, Zhou J, Wang J, Zhang Y, Fang RH, Zhang L, Lu W. Chai Z, et al. Among authors: zhou j. ACS Nano. 2019 May 28;13(5):5591-5601. doi: 10.1021/acsnano.9b00661. Epub 2019 May 13. ACS Nano. 2019. PMID: 31070352

4

Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma.

Guo H, Wang R, Wang D, Wang S, Zhou J, Chai Z, Yao S, Li J, Lu L, Liu Y, Xie C, Lu W. Guo H, et al. Among authors: zhou j. J Control Release. 2020 Apr 10;320:63-72. doi: 10.1016/j.jconrel.2020.01.005. Epub 2020 Jan 7. J Control Release. 2020. PMID: 31917294

5

ɑ_vβ₃-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy.

Li J, Chai Z, Lu J, Xie C, Ran D, Wang S, Zhou J, Lu W. Li J, et al. Among authors: zhou j. J Control Release. 2020 Jun 10;322:542-554. doi: 10.1016/j.jconrel.2020.04.009. Epub 2020 Apr 8. J Control Release. 2020. PMID: 32277962

6

A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated.

Li J, Lu J, Guo H, Zhou J, Wang S, Jiang K, Chai Z, Yao S, Wang X, Lu L, Xie C, Chen Y, Lu W. Li J, et al. Among authors: zhou j. Acta Pharm Sin B. 2021 Jan;11(1):283-299. doi: 10.1016/j.apsb.2020.07.024. Epub 2020 Aug 13. Acta Pharm Sin B. 2021. PMID: 33532193 Free PMC article.

7

Hydrogel loading functionalized PAMAM/shRNA complex for postsurgical glioblastoma treatment.

Song J, Zhang H, Wang D, Wang J, Zhou J, Zhang Z, Wang J, Hu Y, Xu Q, Xie C, Lu W, Liu M. Song J, et al. Among authors: zhou j. J Control Release. 2021 Oct 10;338:583-592. doi: 10.1016/j.jconrel.2021.08.052. Epub 2021 Sep 2. J Control Release. 2021. PMID: 34481020

8

Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma.

Hu Y, Jiang K, Wang D, Yao S, Lu L, Wang H, Song J, Zhou J, Fan X, Wang Y, Lu W, Wang J, Wei G. Hu Y, et al. Among authors: zhou j. Acta Biomater. 2022 Jan 15;138:478-490. doi: 10.1016/j.actbio.2021.10.042. Epub 2021 Oct 29. Acta Biomater. 2022. PMID: 34757231

9

All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.

Wu S, Lu L, Zhou J, Ran D, Wang S, Xu Q, Xu W, Wang J, Liu Y, Xie C, Luo Z, Lu W. Wu S, et al. Among authors: zhou j. J Control Release. 2022 May;345:685-695. doi: 10.1016/j.jconrel.2022.03.047. Epub 2022 Mar 26. J Control Release. 2022. PMID: 35346767

10

In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy.

Luo Z, Lu L, Xu W, Meng N, Wu S, Zhou J, Xu Q, Xie C, Liu Y, Lu W. Luo Z, et al. Among authors: zhou j. J Control Release. 2022 Jun;346:32-42. doi: 10.1016/j.jconrel.2022.03.058. Epub 2022 Apr 1. J Control Release. 2022. PMID: 35378211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,047 results

Search Page

Filters